EUVIMEDEUVIMED entdecken
Crossref

A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia

Mika Hori iD, Atsushi Takahashi iD, Kiminori Hosoda, Masatsune Ogura, Mariko Harada-Shiba

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgac572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Mika Hori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Hypercholesterolemia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Kanae Foundation for the Promotion of Medical Science, Japanese Circulation Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Heterozygous familial hypercholesterolemia (HeFH) is caused by a rare pathogenic variant in the LDLR, APOB, and PCSK9 genes. However, the causative variants in these genes have not been identified in approximately 40% of HeFH patients.

Objective

Our aim was to identify novel (or additional) genes/variants that contribute to HeFH.

Methods

Whole-exome sequencing was performed for 215 family members from 122 families with HeFH without pathogenic variants in the LDLR or PCSK9 genes.

Results

We could not find novel causative familial hypercholesterolemia (FH) genes/variants by family analysis. Next, we examined all APOB variants. Twenty-four nonsynonymous APOB variants were identified. The allele frequencies of the c.2863C > T:p.(Pro955Ser) variant in the HeFH probands and the general Japanese population were 0.15 and 0.034, respectively [odds ratio 4.9 (95% CI 3.4-7.1); P = 6.9 × 10−13]. The patients harboring the c.2863C > T:p.(Pro955Ser) variant accounted for 9.8% (n = 63) of unrelated patients with HeFH (n = 645). The penetrance of the c.2863C > T:p.(Pro955Ser) variant was low in the pedigree-based genetic analysis. In an in vitro assay, low-density lipoprotein (LDL) uptake from patients with the homozygous c.2863C > T:p.(Pro955Ser) variant was 44% of the LDL uptake from control subjects, and it was similar to that of the LDL uptake from patients with the known pathogenic heterozygous p.(Arg3527Gln) variant.

Conclusions

The low-frequency APOB c.2863C > T:p.(Pro955Ser) variant is not an FH-causative variant, but it has a moderate effect size in HeFH. These findings suggest that the combination of the APOB c.2863C > T:p.(Pro955Ser) variant and age, environmental factors, or other genetic factors contributes to the severity of or variability in the HeFH phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperlipoproteinemia Type IIHypercholesterolemiaHumansProprotein Convertase 9Receptors, LDLPhenotypeApolipoproteins BMutation

Stichwörter der Autor:innen

APOBJapaneseLDLexome sequencingfamilial hypercholesterolemialow-frequency variant

Substanzen

PCSK9 protein, humanProprotein Convertase 9Receptors, LDLApolipoproteins B

Autor:innen und Institutionen

  • Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
  • Department of Endocrinology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Aichi, Japan.
  • Department of Endocrinology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Department of Genomic Medicine, National Cerebral and Cardiovascular Center Research Institute, Suita, Osaka, Japan.
  • Laboratory of Clinical Genetics, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
  • Department of Diabetes and Lipid Metabolism, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.

ORCID-Profile: Mika Hori, Atsushi Takahashi

Förderung

  • Kanae Foundation for the Promotion of Medical Science
  • Japanese Circulation Society

Zitieren

APA

Hori, M., Takahashi, A., Hosoda, K., Ogura, M., & Harada-Shiba, M. (2023). A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgac572

Vancouver

Hori M, Takahashi A, Hosoda K, Ogura M, Harada-Shiba M. A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgac572

BibTeX
@article{Hori2023,
  author = {Hori, Mika and Takahashi, Atsushi and Hosoda, Kiminori and Ogura, Masatsune and Harada-Shiba, Mariko},
  title = {A Low-Frequency APOB p.(Pro955Ser) Variant Contributes to the Severity of/Variability in Familial Hypercholesterolemia},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgac572}
}
Kostenlos starten →